INFOCURE CORP
5, 1999-02-16
PREPACKAGED SOFTWARE
Previous: GENESIS DEVELOPMENT & CONSTRUCTION LTD, SC 13G, 1999-02-16
Next: INFOCURE CORP, 5/A, 1999-02-16



<PAGE>
 
<TABLE> 
<CAPTION> 

<S>                           <C>                                                          <C> 
                                                                                            --------------------------------------
                                                                                                      OMB APPROVAL 
- ------                         U.S. SECURITIES AND EXCHANGE COMMISSION                      OMB Number          3235-0362           
FORM 5                                 Washington, D.C. 20549                               Expires:            September 30, 1998  
- ------                                                                                      Estimated average                       
                                                                                            burden hours per                        
                                                                                            response........    1.0
                                                                                            ---------------------------------------

[_] Check this box if no longer                               ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 
     subject to Section 16. Form 4 
     or Form 5 obligations may                Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section    
     continue.  See Instruction 1(b).                                   17(a) of the Public Utility                              
[_]  Form 3 Holdings Reported                  Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of     
[_]  Form 4 Transactions Reported                                                   1940                                          
(PRINT OR TYPE RESPONSES)
- ------------------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person*                                    4.  Statement for Month/Year                            

  Chastain           R.             Ernest                                                  Year Ending 12/31/98 
- -------------------------------------------------------                     ------------------------------------------------------- 
   (Last)         (First)          (Middle)                                 5.  If Amendment, Date of Original          

                                                                                (Month/Year)                                        
   c/o InfoCure Corporation                                                                             
   1765 The Exchange, Suite 450                                             ------------------------------------------------------- 
- -------------------------------------------------------                     6.  Relationship of Reporting Person to Issuer
                      (Street)                                                          (Check all applicable)                  
                                                                                  
Atlanta           Georgia             30339                                     [_] Director                  [_]  10% Owner
- -------------------------------------------------------                         [X] Officer (give title       [_]  Other (specify
(City)            (State)             (Zip)                                                  below)                       below) 
                                                                                                                                 
- -------------------------------------------------------                                Vice-President - Sales & Marketing
2.  Issuer Name and Ticker or Trading Symbol                                -------------------------------------------------------
                                                                            7. Individual or Joint/Group Filing                    
         InfoCure Corporation (INCX)                                                  (Check Applicable Line)
- -------------------------------------------------------                         [X] Form filed by One Reporting Person             
3.  IRS or Social Security Number of Reporting                                  [_] Form filed by More than One Reporting Person   
    Person (Voluntary)                                                      -------------------------------------------------------
                                                       
- ------------------------------------------------------- 

- ------------------------------------------------------------------------------------------------------------------------------------
                         TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
- ------------------------------------------------------------------------------------------------------------------------------------
1. Title of Security (Instr. 3)                                             2.  Transaction Date (Month/Day/Year)
- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     -------------------------------------------------------

3. Transaction Code (Instr. 8)                                              4. Securities Acquired (A) or Disposed of (D)           
                                                                               (Instr. 3, 4 and 5)                                  
                      Code                                                                                                          
                                                                                 Amount         (A) or (D)             Price        
- -------------------------------------------------------                                                                             
                                                                            ------------------------------------------------------- 
- -------------------------------------------------------                                                                             
                                                                            ------------------------------------------------------- 
- -------------------------------------------------------                                                                             
                                                                            ------------------------------------------------------- 
- -------------------------------------------------------                                                                             
                                                                            ------------------------------------------------------- 
- -------------------------------------------------------                                                                             
                                                                            ------------------------------------------------------- 
                                                         
5. Amount of Securities Beneficially Owned at End of                        6. Ownership Form:  Direct (D) or Indirect (I)          
   Issuer's Fiscal Year (Instr. 3 and 4)                                       (Instr. 4)                                           
                                                                                                                                    
- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

7. Nature of Indirect Beneficial Ownership (Instr. 4)

- ------------------------------------------------------- 

- ------------------------------------------------------- 

- ------------------------------------------------------- 

- ------------------------------------------------------- 

- ------------------------------------------------------- 

- ------------------------------------------------------------------------------------------------------------------------------------

Reminder:  Report on a separate line for each class of securities beneficially owned directly or indirectly.                  (Over)

 * If the Form is filed by more than one reporting person, see Instructions 4(b)(v).                                 SEC 2270 (7/96)

</TABLE> 
<PAGE>
 
<TABLE> 
<CAPTION> 

<S>                                                                         <C> 
1. Title of Derivative Security (Instr. 3)                                  2. Conversion or Exercise Price of Derivative Security

- -------------------------------------------------------                     ------------------------------------------------------- 
           Stock Option (Right to Buy)                                                                  $ 9.31
- -------------------------------------------------------                     ------------------------------------------------------- 
           Stock Option (Right to Buy)                                                                  $11.63
- -------------------------------------------------------                     ------------------------------------------------------- 
           Stock Option (Right to Buy)                                                                  $20.00
- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

3. Transaction Date (Month/Day/Year)                                        4. Transaction Code (Instr. 8)

- -------------------------------------------------------                                            Code
                    12/2/97                                                                          
- -------------------------------------------------------                     ------------------------------------------------------- 
                    10/23/98                                                                         A5
- -------------------------------------------------------                     ------------------------------------------------------- 
                     12/2/98                                                                         A 
- -------------------------------------------------------                     ------------------------------------------------------- 
                                                                                                     A
- -------------------------------------------------------                     ------------------------------------------------------- 

                                                                            ------------------------------------------------------- 

5. Number of Derivative Securities Acquired (A) or                          6. Date Exercisable and Expiration Date
   Disposed of (D) (Instr. 3, 4 and 5)                                         (Month/Day/Year)

               (A)               (D)                                             Date Exercisable              Expiration Date

- -------------------------------------------------------                     ------------------------------------------------------
                50                                                                   12/2/01                      12/2/07
- -------------------------------------------------------                     ------------------------------------------------------- 
             2,006                                                                     (1)                        10/23/98
- -------------------------------------------------------                     ------------------------------------------------------- 
                50                                                                   12/2/02                      12/2/08
- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     ------------------------------------------------------- 

7. Title and Amount of Underlying Securities                                8. Price of Derivative Security (Instr. 5)
   (Instr. 3 and 4)
                                                                            ------------------------------------------------------- 
      Title             Amount or Number of Shares
- -------------------------------------------------------                     ------------------------------------------------------- 
Common Stock                     50
- -------------------------------------------------------                     ------------------------------------------------------- 
Common Stock                  2,006
- -------------------------------------------------------                     ------------------------------------------------------- 
Common Stock                     50
- -------------------------------------------------------                     ------------------------------------------------------- 

- -------------------------------------------------------                     10. Ownership Form of Derivative Security. Direct (D)   
                                                                                or Indirect (I) (Instr. 4)                          
9. Number of Derivative Securities Beneficially Owned                       
   at End of Year (Instr. 4)                                                -------------------------------------------------------
                                                                                                                                   
- -------------------------------------------------------                     -------------------------------------------------------
                    50                                                                                  D
- -------------------------------------------------------                     -------------------------------------------------------
                 2,006                                                                                  D
- -------------------------------------------------------                     -------------------------------------------------------
                    50                                                                                  D
- -------------------------------------------------------                     -------------------------------------------------------

- -------------------------------------------------------  
                                                                                                                  
11. Nature of Indirect Beneficial Ownership (Instr. 4)                                                            
                                                                                                                  
- -------------------------------------------------------  

- -------------------------------------------------------  

- -------------------------------------------------------                                                           

- -------------------------------------------------------                                                           

- -------------------------------------------------------                                                           
- ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses:

(1)  As of 10/23/98 exercisable as to 501 shares; as of 10/23/99 exercisable as to 1,002 shares; as of 10/23/01 exercisable as to 
     1,504 shares; as of 10/23/02 exercisable as to 2,006 shares.

**Intentional misstatements or omissions of fact constitute Federal Criminal
  Violations.  See 18 U.S.C. 1001 and 15 U.S.C. 7811(a).

Note:  File three copies of this Form, one of which must be manually signed.


                                                                                       /s/ R. Ernest Chastain
                                                                                 --------------------------------------------------
                                                                                          ** Signature of Reporting Person
                                                                                                R. Ernest Chastain

                                                                                                  February 15, 1999
                                                                                 --------------------------------------------------
                                                                                                       Date

</TABLE> 
 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission